Geron Company Description

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia.

The company was incorporated in 1990 and is headquartered in Foster City, California.

Geron Corporation

Country	United States
Founded	1990
Industry	Medical - Pharmaceuticals
Sector	Healthcare
Employees	229
CEO	Harout Semerjian

Contact Details

Address: 919 East Hillsdale Boulevard Foster City, Delaware 94404 United States
Phone	650 473 7700
Website	geron.com

Stock Details

Ticker Symbol	0IV3
Exchange	London Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US3741631036
SIC Code	2836

Key Executives

Name	Position
Harout Semerjian	Chief Executive Officer, President and Director
Michelle J. Robertson	Executive Vice President, Chief Financial Officer, Treasurer and Principal Financial and Accounting Officer
Dr. Andrew J. Grethlein Ph.D.	Executive Vice President and Chief Operating Officer
James Ziegler M.B.A.	Executive Vice President and Chief Commercial Officer
Dr. Joseph Emile Eid M.D.	Executive Vice President of Research and Development
Aron Feingold	Vice President of Investor Relations and Corporate Communications
Scott Samuels	Executive Vice President, Chief Legal Officer and Secretary
Shannon T. Odam	Executive Vice President and Chief People Officer
Dr. Faye Feller M.D.	Executive Vice President and Chief Medical Officer